Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The American Journal of Cardiology|September 8, 2009
Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritisWilliam B White, Thomas J Schnitzer, Rosanna Fleming, et al.
NPJ Primary Care Respiratory Medicine|October 8, 2022
Breaking the vicious circle-the Asthma Referral Identifier (ReferID) toolMaarten Beekman, Julie Hales, Mona Al-Ahmad, et al.
Seminars in Arthritis and Rheumatism|September 11, 2010
Efficacy and safety of naproxcinod in patients with osteoarthritis of the knee: a 53-week prospective randomized multicenter studyThomas J Schnitzer, Marc C Hochberg, Christopher E Marrero, et al.
Pharmaceutical Medicine|September 19, 2020
Developing Medical Affairs Leaders Who Create the FutureAlexander Bedenkov, Viraj Rajadhyaksha, Maarten Beekman, et al.
BMC Pulmonary Medicine|February 18, 2022
Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional studyHamdan Al-Jahdali, Siraj Wali, Amr S Albanna, et al.
The Clinical Respiratory Journal|October 24, 2022
Overprescription of short-acting β<sub>2</sub> -agonists among patients with asthma in Saudi Arabia: Results from the SABINA III cohort studyHamdan Al-Jahdali, Siraj Wali, Amr S Albanna, et al.
Asthma Research and Practice|July 7, 2022
Over-prescription of short-acting β<sub>2</sub>-agonists and asthma management in the Gulf region: a multicountry observational studyAshraf Alzaabi, Nasser Al Busaidi, Rohit Pradhan, et al.
Journal of Asthma and Allergy|September 2, 2022
A Cross-Sectional Study on Prescription Patterns of Short-Acting β<sub>2</sub>-Agonists in Patients with Asthma: Results from the SABINA III Colombia CohortJohn Carlos Pedrozo-Pupo, Manuel Conrado Pacheco Gallego, Iván de Jesús Baños Álvarez, et al.
Pageof 2